Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for DiaSorin S.p.A. (DSRLF : OTC)
 
 • Company Description   
DiaSorin S.p.A. engages in the development, production and marketing of reagent kits for in vitro diagnostics. It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which serves infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology and endocrinology clinical areas. DiaSorin S.p.A. is headquartered in Vercelli, Italy.

Number of Employees: 3,186

 
 • Price / Volume Information   
Yesterday's Closing Price: $107.68 Daily Weekly Monthly
20 Day Moving Average: 106 shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta: -0.01
52 Week High: $112.30
52 Week Low: $100.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 2.85% -2.72%
12 Week -1.75% -17.58%
Year To Date 0.77% -5.61%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Via Crescentino snc
-
Saluggia,L6 13040
ITA
ph: 39-01-6148-7526
fax: -
riccardo.fava@diasorin.com https://int.diasorin.com
 
 • General Corporate Information   
Officers
CarloRosa - Chief Executive Officer
Chen Menachem Even - Chief Commercial Officer
Piergiorgio Pedron - Corp. Accounting Documents Officer
Riccardo Fava - Sr. Director of Investor Relations & Corp. Communi
Ulisse Spada - Mang. of Corp. Legal Affairs Department

Peer Information
DiaSorin S.p.A. (BJCT)
DiaSorin S.p.A. (CADMQ)
DiaSorin S.p.A. (APNO)
DiaSorin S.p.A. (UPDC)
DiaSorin S.p.A. (IMTIQ)
DiaSorin S.p.A. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: T3475Y104
SIC: 8880
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta: -0.01
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: 11.85
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 3.51
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 2.26
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - 20.45
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - -
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - 1.20
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©